Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study to Test if TEV-48574 is Effective in Relieving Asthma

ClinicalTrials.gov ID: NCT04545385

Public ClinicalTrials.gov record NCT04545385. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 8:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma

Study identification

NCT ID
NCT04545385
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Industry
Enrollment
65 participants

Conditions and interventions

Conditions

Interventions

  • TEV-48574 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2020
Primary completion
Jan 16, 2022
Completion
Jan 16, 2022
Last update posted
Mar 12, 2023

2020 – 2022

United States locations

U.S. sites
55
U.S. states
21
U.S. cities
50
Facility City State ZIP Site status
Teva Investigational Site 14884 Birmingham Alabama 35209
Teva Investigational Site 14915 Little Rock Arkansas 72205
Teva Investigational Site 14914 Bakersfield California 93301
Teva Investigational Site 15234 Huntington Beach California 92647
Teva Investigational Site 14896 Los Angeles California 90025
Teva Investigational Site 14918 Los Angeles California 90025
Teva Investigational Site 14913 Los Angeles California 90048
Teva Investigational Site 14910 Rolling Hills Estates California 90274-7604
Teva Investigational Site 14907 San Diego California 92123
Teva Investigational Site 14891 San Jose California 95117
Teva Investigational Site 15231 Stockton California 95207
Teva Investigational Site 14916 Walnut Creek California 94598
Teva Investigational Site 14878 Westminster California 92683
Teva Investigational Site 14895 Colorado Springs Colorado 80907
Teva Investigational Site 14917 Denver Colorado 80246
Teva Investigational Site 15222 Coral Gables Florida 33134
Teva Investigational Site 15223 Cutler Bay Florida 33189
Teva Investigational Site 14911 Hialeah Florida 33012
Teva Investigational Site 15225 Hialeah Florida 33015
Teva Investigational Site 14900 Miami Florida 33134
Teva Investigational Site 14883 Miami Florida 33173
Teva Investigational Site 14908 Panama City Florida 32405
Teva Investigational Site 14894 Tallahassee Florida 32308-4355
Teva Investigational Site 15224 Tampa Florida 33607
Teva Investigational Site 14924 Evansville Indiana 47713
Teva Investigational Site 14897 Kansas City Kansas 66160
Teva Investigational Site 15220 Baltimore Maryland 21236
Teva Investigational Site 14877 North Dartmouth Massachusetts 02747-3322
Teva Investigational Site 14922 St Louis Missouri 63110
Teva Investigational Site 14893 St Louis Missouri 63141
Teva Investigational Site 14904 Missoula Montana 59808
Teva Investigational Site 14912 Bellevue Nebraska 68123-4303
Teva Investigational Site 14903 Lincoln Nebraska 68505-2343
Teva Investigational Site 15227 Skillman New Jersey 08558
Teva Investigational Site 15221 Charlotte North Carolina 28277
Teva Investigational Site 15226 Monroe North Carolina 28112
Teva Investigational Site 14882 Raleigh North Carolina 27607
Teva Investigational Site 14887 Wilmington North Carolina 28401
Teva Investigational Site 14889 Cincinnati Ohio 45231
Teva Investigational Site 14886 Dublin Ohio 43016
Teva Investigational Site 14901 Toledo Ohio 43617
Teva Investigational Site 14888 Edmond Oklahoma 73034
Teva Investigational Site 14880 Oklahoma City Oklahoma 73112-4432
Teva Investigational Site 14923 Philadelphia Pennsylvania 19140
Teva Investigational Site 14890 Charleston South Carolina 29406
Teva Investigational Site 14925 Allen Texas 75013
Teva Investigational Site 15230 Austin Texas 78759
Teva Investigational Site 14909 Dallas Texas 75231
Teva Investigational Site 14902 El Paso Texas 79903-3508
Teva Investigational Site 14919 Fort Worth Texas 76244
Teva Investigational Site 14921 Houston Texas 77030
Teva Investigational Site 14905 McKinney Texas 75069
Teva Investigational Site 14879 San Antonio Texas 78229
Teva Investigational Site 14920 Spokane Washington 99204
Teva Investigational Site 14881 Greenfield Wisconsin 53228

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04545385, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2023 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04545385 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →